Skip to main content
. 2020 Oct;9(5):1313–1327. doi: 10.21037/gs-20-366

Table 1. General characteristics of patients undergoing modified radical mastectomy (MRM) for cancer.

Treatment group (n=41) Placebo/control group (n=40) P value 95% confidence interval of the difference
Lower Upper
Age (years) 49±7 51.7±8 0.13 −0.82 6.30
BMI (kg/m2) 26.7±3.65 26.0±2.72 0.39 −1.40 1.40
Normal weight/overweight, n (%) 33 (80.5%) 35 (87.5%) 0.64 0.67 0.85
Obesity grade I and II (%) 8 (19.5) 5 (12.5%)
Allergies, n (%) 1 (2.4%) 2 (5%) 0.52 0.64 0.84
Diabetes or hypertension, n (%) 3 (7.3%) 4 (10%) 0.67 0.76 0.92
Smoking, n (%) 4 (9.7%) 6 (15%) 0.47 0.20 0.40
Neoadjuvant therapy, n (%) 5 (12.2%) 5 (12.5%) 0.86 0.96 1.00
Modified radical mastectomy, n (%) 21 (51.2%) 20 (50%) 0.91 0.96 1.00
Modified radical mastectomy with reconstruction, n (%) 20 (48.8%) 20 (50%)
Operative time (min) 114.3±18.7 108.4±18.8 0.16 −7.70 8.80
Endotracheal tube removal time (min) 139.0±20.6 135.2±25.6 0.4 −5.30 13.70
Bleeding (mL) 123.0±28.9 120±27.1 0.64 −2.30 16.80
Time to removal of closed drainage system (days) 7.2±1.3 7.0±1.2 0.48 −0.78 0.60

Values are expressed as means ± standard deviation. BMI, body mass index.